Publications

Found 3 results
Filters: Author is Z.W. Du  [Clear All Filters]
2016
X. N. Wang, Yang, Q. W., Du, Z. W., Yu, T., Qin, Y. G., Song, Y., Xu, M., Wang, J. C., Wang, X. N., Yang, Q. W., Du, Z. W., Yu, T., Qin, Y. G., Song, Y., Xu, M., and Wang, J. C., Evaluation of the stability of reference genes in bone mesenchymal stem cells from patients with avascular necrosis of the femoral head, vol. 15, p. -, 2016.
X. N. Wang, Yang, Q. W., Du, Z. W., Yu, T., Qin, Y. G., Song, Y., Xu, M., Wang, J. C., Wang, X. N., Yang, Q. W., Du, Z. W., Yu, T., Qin, Y. G., Song, Y., Xu, M., and Wang, J. C., Evaluation of the stability of reference genes in bone mesenchymal stem cells from patients with avascular necrosis of the femoral head, vol. 15, p. -, 2016.
Y. H. Liu and Du, Z. W., Management of clinically negative nodes (N0) in supraglottic laryngeal carcinoma: A systematic review, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.REFERENCESAmerican Cancer Society (2013). Cancer facts & figures: 2013. American Cancer Society, Atlanta. Arens C, et al (2012). Transoral treatment strategies for head and neck tumors. GMS Curr. Top. Otorhinolaryngol. Head Neck Surg. 11: Doc05. Brazilian Head and Neck Cancer Study Groupet al (1999). End results of a prospective trial on elective lateral neck dissection vs type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas. Head Neck 21: 694-702. http://dx.doi.org/10.1002/(SICI)1097-0347(199912)21:8<694::AID-HED3>3.0.CO;2-B Canis M, Martin A, Ihler F, Wolff HA, et al (2013). Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients. Eur. Arch. Otorhinolaryngol. 270: 2315-2326. http://dx.doi.org/10.1007/s00405-012-2327-6 Chawla S, Carney AS, et al (2009). Organ preservation surgery for laryngeal cancer. Head Neck Oncol. 1: 12-15. http://dx.doi.org/10.1186/1758-3284-1-12 Li A, Liang H, Li W, Wang Z, et al (2013). Spectral CT imaging of laryngeal and hypopharyngeal squamous cell carcinoma: evaluation of image quality and status of lymph nodes. PLoS One 8: e83492. http://dx.doi.org/10.1371/journal.pone.0083492 Li JZ, Gao W, Chan JY, Ho WK, et al (2012). Hypoxia in head and neck squamous cell carcinoma. ISRN Otolaryngol. 2012: 708974. http://dx.doi.org/10.5402/2012/708974 Liu J, et al (2001). Evaluation of the system of non-randomized studies. Chinese Journal of Evidence-Based Medicine 1: 239-243. McLeod RS, et al (1999). Issues in surgical randomized controlled trials. World J. Surg. 23: 1210-1214. http://dx.doi.org/10.1007/s002689900649 Mutlu V, Ucuncu H, Altas E, Aktan B, et al (2014). The relationship between the localization, size, stage and histopathology of the primary laryngeal tumor with neck metastasis. Eurasian J Med 46: 1-7. http://dx.doi.org/10.5152/eajm.2014.01 Orús C, León X, Vega M, Quer M, et al (2000). Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy. Eur. Arch. Otorhinolaryngol. 257: 512-516. http://dx.doi.org/10.1007/s004050000276 Parmar MKB, Torri V, Stewart L, et al (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat. Med. 17: 2815-2834. http://dx.doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 Pillsbury HC3rdClarkM, et al (1997). A rationale for therapy of the N0 neck. Laryngoscope 107: 1294-1315. http://dx.doi.org/10.1097/00005537-199710000-00004 Redaelli de Zinis LO, Nicolai P, Barezzani MG, Tomenzoli D, et al (1994). Incidence and distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Acta. Otorhinolaryngol. Ital. 14: 19-27.Sessions DG, Lenox J and Spector GJ (2005). Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope 115: 1402-1410. Ji W, Yu J, Guan C, et al (2001). Pathologic features of occult lymphatic metastasis in supraglottic carcinoma. Chin. Med. J. (Engl.) 114: 88-89. Sessions DG, Lenox J, Spector GJ, et al (2005). Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope 115: 1402-1410. http://dx.doi.org/10.1097/01.MLG.0000166896.67924.B7 Siegel R, Naishadham D, Jemal A, et al (2013). Cancer statistics, 2013. CA Cancer J. Clin. 63: 11-30. http://dx.doi.org/10.3322/caac.21166 Spriano G, Antognoni P, Piantanida R, Varinelli D, et al (1997). Conservative management of T1-T2N0 supraglottic cancer: a retrospective study. Am. J. Otolaryngol. 18: 299-305. http://dx.doi.org/10.1016/S0196-0709(97)90023-5 Tantiwongkosi B, Yu F, Kanard A, Miller FR, et al (2014). Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma. World J. Radiol. 6: 177-191. http://dx.doi.org/10.4329/wjr.v6.i5.177 Zhang H (2009). Dissection in the management of the clinically negative neck (N_0) supraglottic laryngeal squamous cell carcinoma. Available at [http://cdmd.cnki. com.cn/Article/CDMD-10114-2009123560.htm].